Similarly, the designed targets CD19 and BCMA were efficiently expressed and delivered at HEp-2 cell surface from 4 h p.i. to 96 h p.i. (Figure 1E), which indicated that T7011 infection can deliver and display the CAR targets on the tumor cell surface, as well as the release of CCL5 for up to 4 days. This evidence concerns the gene CD19 and infection.